LCAV special stockholder meeting to approve merger on go for May 7

Attorneys representing the litigants opposing the proposed merger between LCA-Vision (LCAV -0.2%) and PhotoMedex (PHMD -0.5%) withdraw their motion for a preliminary injunction against the shareholder vote after LCAV makes additional disclosures about its selection of the Cain Brothers firm as its financial advisor and the negotiations of employment agreements between PHMD and four LCAV executives.

One disclosure states that the Cain Brothers' LCAV valuation range of $3.48 - $4.50 compares favorably to the $5.37 offer price.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs